HealthEquity, Inc. $HQY Stake Raised by Clough Capital Partners L P

Key Points

• Clough Capital Partners L P significantly increased its stake in HealthEquity, Inc. by 133.9% in the first quarter, owning approximately 87,000 shares worth about $7.7 million.
• Several research analysts upgraded HealthEquity to a Buy rating, with price targets ranging from $98 to $125, leading to an average target price of about $117.82.
• HealthEquity reported a quarterly earnings of $0.97 per share, exceeding estimates and setting a positive outlook, with guidance for FY 2026 EPS between $3.610 and $3.78.

Clough Capital Partners L P boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 133.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 87,000 shares of the company's stock after buying an additional 49,800 shares during the period. Clough Capital Partners L P owned 0.10% of HealthEquity worth $7,688,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Stifel Financial Corp raised its position in HealthEquity by 15.4% in the fourth quarter. Stifel Financial Corp now owns 22,232 shares of the company's stock valued at $2,133,000 after purchasing an additional 2,964 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of HealthEquity by 7.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 58,357 shares of the company's stock worth $5,600,000 after acquiring an additional 4,263 shares during the last quarter. Northern Trust Corp increased its position in shares of HealthEquity by 11.7% during the fourth quarter. Northern Trust Corp now owns 1,155,043 shares of the company's stock worth $110,826,000 after acquiring an additional 121,001 shares during the last quarter. Kapitalo Investimentos Ltda purchased a new stake in shares of HealthEquity during the fourth quarter worth about $90,000. Finally, Aristeia Capital L.L.C. purchased a new stake in shares of HealthEquity during the fourth quarter worth about $209,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Barrington Research reiterated an "outperform" rating and issued a $125.00 price target on shares of HealthEquity in a research note on Friday. Royal Bank Of Canada decreased their price target on HealthEquity from $117.00 to $109.00 and set an "outperform" rating for the company in a research note on Thursday. Bank of America lifted their price target on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. JMP Securities lifted their price target on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. Finally, Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 price target (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average price target of $117.82.

HealthEquity Stock Performance

HQY stock traded up $1.04 during midday trading on Monday, reaching $89.33. The company had a trading volume of 1,519,644 shares, compared to its average volume of 946,119. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average price of $95.50 and a 200 day moving average price of $95.57. HealthEquity, Inc. has a fifty-two week low of $73.84 and a fifty-two week high of $116.65. The firm has a market capitalization of $7.72 billion, a PE ratio of 65.20, a P/E/G ratio of 1.38 and a beta of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same period in the previous year, the firm posted $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. Analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Buying and Selling at HealthEquity

In other news, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the sale, the executive vice president owned 75,689 shares of the company's stock, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock worth $32,705,007 over the last ninety days. Company insiders own 1.50% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.